Jun 2, 2026 07:30AM
Feb 24, 2026 07:30AM
Jan 12, 2026 05:05PM
Jan 7, 2026 11:05PM
Jan 7, 2026 11:05PM
Jan 6, 2026 06:14PM
Jan 6, 2026 06:14PM Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
Dec 23, 2025 05:30PM
Nov 4, 2025 07:30AM
May 29, 2025 07:30AM
Nov 4, 2024 07:30AM
May 31, 2024 07:30AM
Jan 5, 2024 05:00PM
Jan 3, 2024 07:01AM Arrowhead Pharmaceuticals Inc. (ARWR) Prices 15.79M Share Offering at $28.50/sh
Jan 3, 2024 07:00AM
Nov 6, 2023 07:30AM
Jun 6, 2023 07:30AM
Jun 7, 2022 07:30AM
Nov 1, 2021 07:30AM
Jun 2, 2021 07:30AM
Nov 9, 2020 07:30AM Arrowhead Pharmaceuticals to Participate in Upcoming Conferences
Jul 29, 2020 01:15PM
May 28, 2020 07:30AM
Dec 6, 2019 04:01PM
Dec 4, 2019 06:01AM
Dec 4, 2019 06:00AM
Dec 2, 2019 04:06PM
Dec 2, 2019 04:05PM Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
May 31, 2019 04:00PM
Mar 1, 2019 07:30AM
Nov 1, 2018 07:30AM
Jun 26, 2018 07:02AM
May 30, 2018 07:25AM
Mar 27, 2018 04:15AM
Jan 22, 2018 04:00PM Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $60.4 Million
Jan 18, 2018 09:31AM
Jan 18, 2018 09:07AM
Jan 18, 2018 09:00AM
Jan 17, 2018 04:01PM
Jan 17, 2018 04:01PM
Nov 30, 2016 08:12AM
Nov 10, 2016 07:54AM Arrowhead Research (ARWR) PT Lowered to $5 at Jefferies Following Clinical Hold
Nov 9, 2016 09:28AM
Jun 3, 2016 07:30AM
Nov 11, 2015 07:30AM
Aug 5, 2015 07:30AM
May 27, 2015 07:30AM
Apr 14, 2015 09:27AM
Apr 14, 2015 06:40AM Jefferies Assumes Coverage, Downgrades Arrowhead Research (ARWR) to Hold
Jan 12, 2015 09:30AM

72,206 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All